Helyszín: Semmelweis Salon, Budapest 26 Üllői út
Dátum: 2019.10.15.
{ "name":"In Memoriam Jozsef Knoll Symposium", "description":"IN MEMORIAM JÓZSEF KNOLL (1925-2018) SYMPOSIUM
The future of deprenyl in pharmacotherapy
16.00 Péter Ferdinandy (Budapest, Hungary) – Opening of the Symposium
1.) Ildikó Miklya (Budapest, Hungary) – Chronology of the milestones in deprenyl research:
in memoriam József Knoll
16.05-16.25
2.) Shizuko Muraoka (Osaka, Japan) – The Selegiline (Deprenyl) Story in Japan: History of Cooperation between Dr. Joseph Knoll and Fujimoto Pharmaceutical Group
16.25-16.40
3.) Fabio Di Lisa (Padua, Italy) – Crucial relevance MAO-B in diseases of cardiac and skeletal muscles
16.40-17.00
4.) Péter Ferdinandy (Budapest, Hungary) – Obesity and MAO-B inhibition
17.00-17.20
17.20 – 17.40 Coffee Break
5.) Dóra Zelena (Budapest, Hungary) – Enhancer’s (deprenyl and BPAP) effect on stress
17.40-18.00
6.) Kornélia Baghy (Budapest, Hungary) – Tumor-manifestation suppressing effect of deprenyl and BPAP
18.00-18.20
7.) László Hársing Jr. (Budapest, Hungary) – Neurotransmission activity enhancer mechanisms (effects on dopaminergic neurotransmission)
18.20-18.40
Péter Ferdinandy (Budapest, Hungary) – Closing remarks
Please send an email to pharmacology@med.semmelweis-univ.hu to notify the organisers about your participation.
IN MEMORIAM JÓZSEF KNOLL (1925-2018) SYMPOSIUM
The future of deprenyl in pharmacotherapy
16.00 Péter Ferdinandy (Budapest, Hungary) – Opening of the Symposium
1.) Ildikó Miklya (Budapest, Hungary) – Chronology of the milestones in deprenyl research:
in memoriam József Knoll
16.05-16.25
2.) Shizuko Muraoka (Osaka, Japan) – The Selegiline (Deprenyl) Story in Japan: History of Cooperation between Dr. Joseph Knoll and Fujimoto Pharmaceutical Group
16.25-16.40
3.) Fabio Di Lisa (Padua, Italy) – Crucial relevance MAO-B in diseases of cardiac and skeletal muscles
16.40-17.00
4.) Péter Ferdinandy (Budapest, Hungary) – Obesity and MAO-B inhibition
17.00-17.20
17.20 – 17.40 Coffee Break
5.) Dóra Zelena (Budapest, Hungary) – Enhancer’s (deprenyl and BPAP) effect on stress
17.40-18.00
6.) Kornélia Baghy (Budapest, Hungary) – Tumor-manifestation suppressing effect of deprenyl and BPAP
18.00-18.20
7.) László Hársing Jr. (Budapest, Hungary) – Neurotransmission activity enhancer mechanisms (effects on dopaminergic neurotransmission)
18.20-18.40
Péter Ferdinandy (Budapest, Hungary) – Closing remarks
Please send an email to pharmacology@med.semmelweis-univ.hu to notify the organisers about your participation.